Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
H Xu, J Shen, J Xiang, H Li, B Li, T Zhang… - Cancer management …, 2019 - Taylor & Francis
… Citation13 Our results also revealed that all three EML4–ALK fusions presented after
resistance were the rare variant V5. The absence of common partners/variants in EGFR TKI–…
resistance were the rare variant V5. The absence of common partners/variants in EGFR TKI–…
Clinically relevant fusion oncogenes: Detection and practical implications
M Sorokin, E Rabushko… - Therapeutic …, 2022 - journals.sagepub.com
… receptor tyrosine kinase (RTK) oncogenic fusion proteins, that is… factors can also cause and
promote genomic instability. The … , which results in the presence of tyrosine kinase domain is …
promote genomic instability. The … , which results in the presence of tyrosine kinase domain is …
Tyrosine kinase receptors in oncology
J Esteban-Villarrubia, JJ Soto-Castillo, J Pozas… - International journal of …, 2020 - mdpi.com
… EML4-ALK fusion gene, resulting from the inversion of the short arm of the chromosome 2,
gives rise to the expression of a chimeric protein with the tyrosine kinase domain constitutively …
gives rise to the expression of a chimeric protein with the tyrosine kinase domain constitutively …
Molecular mechanisms of resistance to tyrosine kinase inhibitors
M Yaghmaie, CCS Yeung - Current Hematologic Malignancy Reports, 2019 - Springer
… The results of mutation analysis may help clinicians in the selection of other TKIs, since …
-ABL1 fusion protein induces genomic instability in CML stem cells and this instability contributes …
-ABL1 fusion protein induces genomic instability in CML stem cells and this instability contributes …
Anaplastic lymphoma kinase fusions: Roles in cancer and therapeutic perspectives
Z Cao, Q Gao, M Fu, NAN Ni, Y Pei… - Oncology …, 2019 - spandidos-publications.com
… results in the formation of chimeric X‑ALK fusion oncoproteins… tyrosine kinase inhibitors
(TKIs), drug resistance eventually develops via an adaptive secondary mutation in the ALK fusion …
(TKIs), drug resistance eventually develops via an adaptive secondary mutation in the ALK fusion …
Drug targeting of genomic instability in multiple myeloma
M Beksac, S Balli, D Akcora Yildiz - Frontiers in Genetics, 2020 - frontiersin.org
… pathways resulting in microsatellite instability (MIN) or mutations. Genomic instability occurs
… In this review, new drugs targeting genomic instability and their mechanisms of action will …
… In this review, new drugs targeting genomic instability and their mechanisms of action will …
Role of genomic instability in human carcinogenesis
… These authors elegantly demonstrated that the oncogenic BCR–ABL fusion gene, resulting
… inhibit DSB repair, block the BCR-ABL tyrosine kinase activity (STI571), or inhibit generation …
… inhibit DSB repair, block the BCR-ABL tyrosine kinase activity (STI571), or inhibit generation …
Protein tyrosine kinases: their roles and their targeting in leukemia
K K. Bhanumathy, A Balagopal, FS Vizeacoumar… - Cancers, 2021 - mdpi.com
… myeloproliferative disease that is characterised by an abnormal fusion … The results of the
study revealed several kinds of D835 … to cause AML but induce a myeloproliferative disease in a …
study revealed several kinds of D835 … to cause AML but induce a myeloproliferative disease in a …
Multiple molecular targets associated with genomic instability in lung cancer
G Soca-Chafre, A Montiel-Dávalos… - … journal of genomics, 2019 - Wiley Online Library
… of tyrosine kinase inhibitors (TKIS) have been developed for EGFR mutations and ALK fusions
… Malfunction of cell cycle controls can result in genomic instability and the accumulation of …
… Malfunction of cell cycle controls can result in genomic instability and the accumulation of …
Targetable gene fusions and aberrations in genitourinary oncology
… (when a genomic region is duplicated, resulting in fusion with a gene in the … to fusions
involving members of the FGFR tyrosine kinase family (FGFR1, FGFR2 and FGFR3) and its fusion …
involving members of the FGFR tyrosine kinase family (FGFR1, FGFR2 and FGFR3) and its fusion …